Jefferies Financial Group Forecasts Strong Price Appreciation for Colgate-Palmolive (NYSE:CL) Stock

Colgate-Palmolive (NYSE:CL) had its price target lifted by equities research analysts at Jefferies Financial Group from $85.00 to $91.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “hold” rating on the stock. Jefferies Financial Group’s target price would indicate a potential downside of 2.24% from the company’s current price.

A number of other research analysts have also weighed in on the company. Morgan Stanley raised their target price on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday. Raymond James Financial cut their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Evercore ISI upped their target price on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Finally, Argus restated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $94.47.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $93.08 on Monday. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. Colgate-Palmolive has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a fifty day moving average of $81.28 and a 200-day moving average of $81.41. The firm has a market capitalization of $75.03 billion, a P/E ratio of 35.53, a P/E/G ratio of 6.18 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the business earned $0.91 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Institutional Trading of Colgate-Palmolive

A number of large investors have recently bought and sold shares of CL. Vanguard Group Inc. grew its stake in shares of Colgate-Palmolive by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock worth $6,633,570,000 after acquiring an additional 1,026,985 shares during the period. Norges Bank purchased a new stake in Colgate-Palmolive during the second quarter valued at about $960,390,000. Invesco Ltd. boosted its position in Colgate-Palmolive by 13.1% during the third quarter. Invesco Ltd. now owns 8,467,993 shares of the company’s stock worth $676,931,000 after purchasing an additional 978,943 shares during the period. Diamond Hill Capital Management Inc. increased its stake in shares of Colgate-Palmolive by 46.7% in the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock worth $645,719,000 after purchasing an additional 2,572,796 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its stake in shares of Colgate-Palmolive by 5.1% in the third quarter. Ameriprise Financial Inc. now owns 6,423,764 shares of the company’s stock worth $517,167,000 after purchasing an additional 314,584 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Company reported stronger-than-expected Q4 results (EPS beat and revenue above consensus), boosting confidence in near-term growth and prompting analyst forecast lifts. Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results
• Positive Sentiment: JPMorgan raised its price target to $97 and kept an “overweight” stance, signaling projected upside and institutional confidence. JPMorgan target raise (Benzinga)
• Positive Sentiment: Bank of America and Evercore ISI lifted targets to $100 (Bank of America) and $100 (Evercore) with buy/outperform views — these upgrades support further upside expectations. Bank of America & Evercore coverage (Benzinga / TickerReport)
• Positive Sentiment: Zacks highlighted CL as a strong growth stock using its Style Scores, adding a retail-oriented, research-backed positive narrative for growth investors. Here’s Why Colgate-Palmolive (CL) is a Strong Growth Stock
• Positive Sentiment: TD Cowen / TipRanks coverage reiterated a bullish thesis around premiumization and the company’s 2030 strategic plan, supporting longer-term confidence among buy-side analysts. TD Cowen: Strengthening earnings visibility and long-term growth
• Neutral Sentiment: Fortune ran a piece on Colgate’s talent rotations and leadership development — positive for long-term culture and management depth but unlikely to move near-term stock price materially. Why Colgate-Palmolive is moving talent across borders to develop leaders
• Negative Sentiment: Deutsche Bank and Jefferies maintained/issued hold ratings with price targets below or near the current level (Deutsche DB raised to $90; Jefferies to $91), which could limit upside or encourage some profit-taking. Deutsche Bank & Jefferies coverage (Benzinga / TickerReport)

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.